Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery
NCT06434948Phase 2Terminated
- Sponsor
- University of Missouri
- Start
- Mar 2026
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in postoperative delirium (POD), sponsored by University of Missouri. Started Mar 2026; status: terminated.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT06434948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06434948.